$PTGX News

Protagonist Therapeutics To Present Four Abstracts On Rusfertide In Polycythemia Vera At 2026 European Hematology Association Congress In Sweden

Protagonist Therapeutics to Participate in Two Investment Bank Conferences in June 2026

Analyst Forecasts For Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Are Surging Higher

Protagonist Therapeutics, Inc. Surprised Analysts With A Profit, And Analysts Boosted Their EPS Forecasts

Is It Too Late To Consider Protagonist Therapeutics (PTGX) After Its 141% One Year Surge?

Citizens Maintains Market Outperform on Protagonist Therapeutics, Raises Price Target to $137

Wedbush Maintains Outperform on Protagonist Therapeutics, Raises Price Target to $118

Protagonist Therapeutics Q1 EPS $0.05 Beats $(0.42) Estimate, Sales $56.368M Beat $16.273M Estimate

Protagonist Therapeutics Inc. (PTGX): Billionaire Tom Steyer Likes Upside Potential of This Stock

Protagonist Therapeutics Exercises Opt-Out Of Rusfertide 50:50 Profit And Loss Sharing Arrangement With Takeda, Eligible For Up To $400M In Opt-Out Payments

Protagonist Therapeutics Reports Granting of Inducement Awards

Truist Securities Maintains Buy on Protagonist Therapeutics, Raises Price Target to $121

Clear Street Maintains Buy on Protagonist Therapeutics, Raises Price Target to $116

Is Protagonist Therapeutics (PTGX) Still Attractive After A 133% One-Year Share Price Surge

Leerink Partners Maintains Outperform on Protagonist Therapeutics, Raises Price Target to $110

Citigroup Maintains Buy on Protagonist Therapeutics, Raises Price Target to $125

Barclays Maintains Overweight on Protagonist Therapeutics, Raises Price Target to $119

Protagonist Therapeutics, Inc. (PTGX) Discusses FDA Approval of ICOTYDE for Moderate to Severe Plaque Psoriasis Treatment Transcript

Protagonist Therapeutics, Inc. (PTGX) Discusses FDA Approval of ICOTYDE for Moderate to Severe Plaque Psoriasis Treatment - Slideshow

Protagonist Therapeutics, Inc. (PTGX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript